RVMD Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 8.00%

Insider Buying (Last 12 Months): $59,999,962.00

Insider Selling (Last 12 Months): $10,891,388.60

Revolution Medicines Insider Trading History Chart

Revolution Medicines Share Price & Price History

^$36.76

▲ +0.56 (1.55%)

As of 04/17/2025 05:00 PM ET

Days: 30 | 90 | 365

Revolution Medicines Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/17/2025	Jack Anders	CFO	Sell	1,864	$39.04	$72,770.56	115,006
3/17/2025	Margaret A. Horn	COO	Sell	3,058	$39.04	$119,384.32	153,533
3/17/2025	Mark A. Goldsmith	Insider	Sell	11,738	$39.04	$458,251.52	441,564
12/16/2024	Jack Anders	CFO	Sell	2,635	$45.40	$119,629.00	96,470
12/16/2024	Margaret A. Horn	COO	Sell	4,329	$45.40	$196,536.60	127,991
12/16/2024	Mark A. Goldsmith	Insider	Sell	11,714	$45.40	$531,815.60	325,056
12/5/2024	Thilo Schroeder	Director	Buy	1,304,347	$46.00	$59,999,962.00	2,096,612
10/14/2024	Stephen Michael Kelsey	Insider	Sell	16,666	$49.49	$824,800.34	264,408
10/11/2024	Jack Anders	CFO	Sell	10,000	$50.30	$503,000.00	98,932
10/11/2024	Jeff Cislini	General Counsel	Sell	6,000	$50.17	$301,020.00	45,634
10/11/2024	Margaret A. Horn	COO	Sell	50,000	$50.34	$2,517,000.00	132,320
10/11/2024	Mark A. Goldsmith	Insider	Sell	30,000	$50.36	$1,510,800.00	300,170
10/8/2024	Barbara Weber	Director	Sell	5,200	$48.02	$249,704.00	13,065
10/1/2024	Mark A. Goldsmith	Insider	Sell	10,000	$44.93	$449,300.00	300,170
8/1/2024	Mark A. Goldsmith	Insider	Sell	10,000	$45.88	$458,800.00	311,885
7/15/2024	Stephen Michael Kelsey	Insider	Sell	16,667	$46.47	$774,515.49	269,073
7/12/2024	Mark A. Goldsmith	Insider	Sell	25,000	$45.05	$1,126,250.00	311,885
7/9/2024	Jeff Cislini	General Counsel	Sell	2,399	$40.83	$97,951.17	47,088
7/9/2024	Sushil Patel	Director	Sell	2,155	$44.00	$94,820.00	19,948
6/26/2024	Jeff Cislini	General Counsel	Sell	2,000	$38.47	$76,940.00	49,487
6/24/2024	Stephen Michael Kelsey	Insider	Sell	200	$39.00	$7,800.00	269,073
5/3/2024	Jack Anders	CFO	Sell	10,000	$40.03	$400,300.00	101,959
4/10/2024	Mark A. Goldsmith	Insider	Sell	7,500	$35.48	$266,100.00	452,879
4/10/2024	Sushil Patel	Director	Sell	2,155	$37.00	$79,735.00	15,700
3/27/2024	Jeff Cislini	General Counsel	Sell	1,500	$30.99	$46,485.00	54,374
3/18/2024	Jack Anders	CFO	Sell	1,261	$31.58	$39,822.38	101,959
3/18/2024	Jeff Cislini	General Counsel	Sell	1,252	$31.58	$39,538.16	55,874
3/18/2024	Margaret A. Horn	COO	Sell	2,914	$31.58	$92,024.12	139,553
3/18/2024	Stephen Michael Kelsey	Insider	Sell	2,123	$31.58	$67,044.34	270,909
1/22/2024	Jeff Cislini	General Counsel	Sell	1,500	$27.00	$40,500.00	36,126
1/8/2024	Stephen Michael Kelsey	Insider	Sell	3,337	$29.01	$96,806.37	221,632
12/27/2023	Stephen Michael Kelsey	Insider	Sell	33,334	$29.01	$967,019.34	238,299
12/18/2023	Jack Anders	CFO	Sell	1,775	$25.90	$45,972.50	76,416
12/18/2023	Jeff Cislini	General Counsel	Sell	1,229	$25.90	$31,831.10	37,284
12/18/2023	Margaret A. Horn	COO	Sell	2,993	$25.90	$77,518.70	101,467
12/18/2023	Mark A. Goldsmith	Insider	Sell	8,165	$25.90	$211,473.50	376,167
12/15/2023	Margaret A. Horn	COO	Sell	5,000	$26.64	$133,200.00	104,460
11/20/2023	Jeff Cislini	General Counsel	Sell	1,500	$21.70	$32,550.00	38,513
10/16/2023	Margaret A. Horn	COO	Sell	25,000	$33.95	$848,750.00	96,960
10/11/2023	Stephen Michael Kelsey	Insider	Sell	16,667	$29.05	$484,176.35	273,721
9/28/2023	Jeff Cislini	General Counsel	Sell	2,000	$28.20	$56,400.00	40,013
9/18/2023	Jack Anders	CFO	Sell	1,427	$31.31	$44,679.37	53,667
9/18/2023	Jeff Cislini	General Counsel	Sell	1,214	$31.31	$38,010.34	42,013
9/18/2023	Margaret A. Horn	COO	Sell	2,514	$31.31	$78,713.34	96,960
9/18/2023	Stephen Michael Kelsey	Insider	Sell	2,060	$31.31	$64,498.60	290,388
9/15/2023	Margaret A. Horn	COO	Sell	5,000	$32.08	$160,400.00	99,474
9/1/2023	Barbara Weber	Director	Sell	15,000	$35.07	$526,050.00	15,825
9/1/2023	Jack Anders	CFO	Sell	20,000	$35.05	$701,000.00	55,094
9/1/2023	Mark A. Goldsmith	Insider	Sell	30,000	$35.05	$1,051,500.00	357,386
8/31/2023	Margaret A. Horn	COO	Sell	10,000	$34.05	$340,500.00	99,474
8/15/2023	Margaret A. Horn	COO	Sell	5,000	$30.53	$152,650.00	99,474
8/1/2023	Stephen Michael Kelsey	Insider	Sell	16,666	$29.19	$486,480.54	309,114
7/31/2023	Jeff Cislini	General Counsel	Sell	1,500	$26.02	$39,030.00	43,227
6/20/2023	Jack Anders	CFO	Sell	1,249	$24.89	$31,087.61	55,094
6/20/2023	Jeff Cislini	General Counsel	Sell	1,239	$25.14	$31,148.46	44,727
6/20/2023	Stephen Michael Kelsey	Insider	Sell	2,102	$24.89	$52,318.78	325,780
3/17/2023	Jack Anders	CFO	Sell	665	$21.78	$14,483.70	55,233
3/17/2023	Margaret A. Horn	Insider	Sell	1,230	$21.78	$26,789.40	100,062
3/10/2023	Thilo Schroeder	Director	Buy	100,000	$20.46	$2,046,000.00	1,553,134
3/7/2023	Thilo Schroeder	Director	Buy	550,000	$22.00	$12,100,000.00	1,453,134
12/19/2022	Jack Anders	CFO	Sell	658	$22.94	$15,094.52	29,298
12/19/2022	Xiaolin Wang	Insider	Sell	708	$22.94	$16,241.52	30,527
10/31/2022	Margaret A. Horn	COO	Sell	17,767	$20.41	$362,624.47	17,767
10/26/2022	Margaret A. Horn	Insider	Sell	17,768	$20.15	$358,025.20	35,534
9/19/2022	Jack Anders	CFO	Sell	449	$19.04	$8,548.96	29,956
9/19/2022	Xiaolin Wang	Insider	Sell	735	$19.04	$13,994.40	31,235
7/22/2022	Lorence H. Kim	Director	Buy	50,000	$20.00	$1,000,000.00	60,500
6/17/2022	Xiaolin Wang	Insider	Sell	665	$17.75	$11,803.75	31,970
6/8/2022	Rock Ventures Iii L.P. Third	Major Shareholder	Sell	419,901	$20.25	$8,502,995.25	5,104,130

SEC Filings (Institutional Ownership Changes) for Revolution Medicines (NASDAQ:RVMD)

94.34% of Revolution Medicines stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Revolution Medicines Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
4/17/2025	Exchange Traded Concepts LLC	3,255	$0.12M	0.0%	-13.4%	0.002%
4/15/2025	Handelsbanken Fonder AB	43,775	$1.55M	0.0%	-1.4%	0.024%
4/15/2025	SG Americas Securities LLC	18,103	$0.64M	0.0%	+516.0%	0.010%
4/15/2025	Avanza Fonder AB	2,877	$100K	0.0%	-27.2%	0.002%
4/14/2025	Harbor Capital Advisors Inc.	35,417	$1.25M	0.1%	N/A	0.019%
4/8/2025	Rhumbline Advisers	257,150	$9.09M	0.0%	+2.3%	0.138%
4/7/2025	GAMMA Investing LLC	21,287	$0.75M	0.0%	+3,501.9%	0.011%
3/18/2025	California State Teachers Retirement System	113,036	$4.94M	0.0%	+1.0%	0.061%
2/27/2025	Jefferies Financial Group Inc.	22,725	$0.99M	0.0%	N/A	0.014%
2/25/2025	Polar Asset Management Partners Inc.	34,600	$1.51M	0.0%	+46.0%	0.021%
2/20/2025	Mackenzie Financial Corp	6,055	$0.27M	0.0%	+17.1%	0.004%
2/19/2025	GF Fund Management CO. LTD.	3,532	$0.15M	0.0%	N/A	0.002%
2/17/2025	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	262,851	$11.50M	0.0%	+21.7%	0.156%
2/17/2025	Voloridge Investment Management LLC	47,851	$2.09M	0.0%	+80.5%	0.028%
2/17/2025	Woodline Partners LP	3,885,713	$169.96M	1.1%	+13.2%	2.310%
2/17/2025	Soleus Capital Management L.P.	201,084	$8.80M	0.6%	-71.5%	0.120%
2/17/2025	Tang Capital Management LLC	100,000	$4.37M	0.3%	N/A	0.059%
2/17/2025	Tema Etfs LLC	45,522	$1.99M	0.8%	N/A	0.027%
2/17/2025	Stempoint Capital LP	193,535	$8.47M	2.1%	+1,062.1%	0.115%
2/17/2025	Sandia Investment Management LP	5,000	$0.22M	0.5%	N/A	0.003%
2/17/2025	Rafferty Asset Management LLC	172,786	$7.56M	0.0%	+2.9%	0.103%
2/17/2025	Polar Asset Management Partners Inc.	34,600	$1.51M	0.0%	+46.0%	0.021%
2/17/2025	Polar Capital Holdings Plc	750,665	$32.83M	0.2%	N/A	0.446%
2/17/2025	ProShare Advisors LLC	55,102	$2.41M	0.0%	+42.5%	0.033%
2/17/2025	MPM Bioimpact LLC	313,817	$13.73M	1.9%	+7.7%	0.187%
2/17/2025	Paradigm Biocapital Advisors LP	6,553,111	$286.63M	10.0%	+23.3%	3.896%
2/17/2025	Man Group plc	321,673	$14.07M	0.0%	+25.6%	0.191%
2/17/2025	Nextech Invest Ltd.	7,601,087	$332.47M	53.9%	+20.7%	4.519%
2/17/2025	Nicholas Investment Partners LP	84,729	$3.71M	0.3%	+36.0%	0.050%
2/17/2025	Nuveen Asset Management LLC	473,728	$20.72M	0.0%	+3.1%	0.282%
2/17/2025	Maven Securities LTD	65,000	$2.84M	0.1%	N/A	0.039%
2/17/2025	MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.	102,127	$4.46M	0.0%	+13.4%	0.061%
2/17/2025	Integral Health Asset Management LLC	550,000	$24.06M	2.1%	+57.1%	0.327%
2/17/2025	J. Goldman & Co LP	26,335	$1.15M	0.0%	N/A	0.016%
2/17/2025	Janus Henderson Group PLC	9,483,999	$414.78M	0.2%	+54.5%	5.638%
2/17/2025	Jefferies Financial Group Inc.	22,725	$0.99M	0.0%	N/A	0.014%
2/17/2025	Granahan Investment Management LLC	119,430	$5.22M	0.2%	-20.0%	0.071%
2/17/2025	Ensign Peak Advisors Inc	305,172	$13.35M	0.0%	+667.1%	0.181%
2/17/2025	Farallon Capital Management LLC	13,248,692	$579.50M	2.9%	+17.1%	7.876%
2/17/2025	Fred Alger Management LLC	148,126	$6.48M	0.0%	-72.6%	0.088%
2/17/2025	D. E. Shaw & Co. Inc.	14,831	$0.65M	0.0%	-62.9%	0.009%
2/17/2025	Deutsche Bank AG	177,383	$7.76M	0.0%	+57.8%	0.105%
2/17/2025	DAFNA Capital Management LLC	631,176	$27.61M	7.0%	+21.9%	0.375%
2/17/2025	Deerfield Management Company L.P. Series C	3,258,332	$142.52M	2.7%	+11.9%	1.937%
2/17/2025	Casdin Capital LLC	3,699,283	$161.81M	10.8%	-10.1%	2.199%
2/17/2025	Brevan Howard Capital Management LP	41,884	$1.83M	0.0%	+277.7%	0.025%
2/17/2025	Avidity Partners Management LP	446,200	$19.52M	1.9%	-43.5%	0.265%
2/17/2025	Baker BROS. Advisors LP	7,936,972	$347.16M	3.7%	+4.9%	4.718%
2/17/2025	BVF Inc. IL	4,181,179	$182.89M	6.2%	+20.2%	2.486%
2/17/2025	Balyasny Asset Management L.P.	1,302,848	$56.99M	0.1%	-21.1%	0.774%
2/17/2025	Bellevue Group AG	4,386,900	$191.88M	3.7%	-9.9%	2.608%
2/17/2025	Bank of America Corp DE	401,043	$17.54M	0.0%	-6.3%	0.238%
2/17/2025	BNP Paribas Financial Markets	248,326	$10.86M	0.0%	N/A	0.148%
2/17/2025	Ameriprise Financial Inc.	1,626,848	$71.16M	0.0%	+9.5%	0.967%
2/17/2025	Algert Global LLC	46,973	$2.06M	0.0%	+17.3%	0.028%
2/17/2025	Acuta Capital Partners LLC	111,700	$4.89M	4.9%	+3.4%	0.066%
2/14/2025	Boxer Capital Management LLC	4,279,464	$187.18M	15.8%	N/A	2.544%
2/14/2025	Kapitalo Investimentos Ltda	2,370	$0.10M	0.1%	N/A	0.001%
2/14/2025	Schonfeld Strategic Advisors LLC	20,000	$0.88M	0.0%	+169.5%	0.012%
2/14/2025	Northern Trust Corp	1,540,078	$67.36M	0.0%	+17.4%	0.916%
2/14/2025	The Manufacturers Life Insurance Company	237,539	$10.39M	0.0%	+11.6%	0.141%
2/14/2025	Artia Global Partners LP	284,190	$12.43M	4.4%	+196.4%	0.169%
2/14/2025	Decheng Capital LLC	226,000	$9.89M	2.1%	+11,200.0%	0.134%
2/14/2025	Aquatic Capital Management LLC	113,405	$4.96M	0.1%	+225.9%	0.067%
2/14/2025	Oxford Asset Management LLP	16,687	$0.73M	0.4%	N/A	0.010%
2/14/2025	Susquehanna Fundamental Investments LLC	228,513	$10M	0.1%	N/A	0.136%
2/14/2025	Ghisallo Capital Management LLC	257,100	$11.25M	0.7%	N/A	0.153%
2/14/2025	Virtus ETF Advisers LLC	1,582	$69K	0.0%	-31.8%	0.001%
2/14/2025	Lord Abbett & CO. LLC	1,978,720	$86.55M	0.3%	+8.0%	1.176%
2/14/2025	Voya Investment Management LLC	316,028	$13.82M	0.0%	+1.2%	0.188%
2/14/2025	Adage Capital Partners GP L.L.C.	650,000	$28.43M	0.0%	+124.1%	0.386%
2/14/2025	Syon Capital LLC	7,306	$0.32M	0.0%	N/A	0.004%
2/14/2025	Hood River Capital Management LLC	1,678,434	$73.42M	1.1%	+25.9%	0.998%
2/14/2025	Price T Rowe Associates Inc. MD	5,865,962	$256.58M	0.0%	+10.4%	3.487%
2/14/2025	Hsbc Holdings PLC	269,294	$11.78M	0.0%	-4.0%	0.160%
2/14/2025	Rock Springs Capital Management LP	1,213,257	$53.07M	2.0%	+20.1%	0.721%
2/14/2025	Tower Research Capital LLC TRC	18,479	$0.81M	0.0%	+672.5%	0.011%
2/14/2025	Natixis	1,170	$51K	0.0%	-98.6%	0.001%
2/14/2025	MetLife Investment Management LLC	100,329	$4.39M	0.0%	+16.1%	0.060%
2/14/2025	Nan Fung Group Holdings Ltd	19,253	$0.84M	0.7%	+163.7%	0.011%
2/14/2025	Dimensional Fund Advisors LP	387,775	$16.96M	0.0%	-1.7%	0.231%
2/14/2025	First Trust Advisors LP	119,920	$5.25M	0.0%	-22.7%	0.071%
2/14/2025	Altium Capital Management LLC	60,000	$2.62M	0.7%	N/A	0.036%
2/13/2025	CANADA LIFE ASSURANCE Co	11,398	$0.50M	0.0%	+5.0%	0.007%
2/13/2025	Marshall Wace LLP	1,504,801	$65.82M	0.1%	+41.3%	0.895%
2/13/2025	Guggenheim Capital LLC	34,961	$1.53M	0.0%	-11.2%	0.021%
2/13/2025	Walleye Capital LLC	212,656	$9.30M	0.0%	-34.3%	0.126%
2/13/2025	Mariner LLC	8,039	$0.35M	0.0%	-7.9%	0.005%
2/13/2025	Barclays PLC	408,614	$17.87M	0.0%	+38.7%	0.243%
2/13/2025	Summit Investment Advisors Inc.	17,287	$0.76M	0.7%	+14.1%	0.010%
2/13/2025	Sterling Capital Management LLC	1,956	$86K	0.0%	+588.7%	0.001%
2/13/2025	Raymond James Financial Inc.	321,611	$14.07M	0.0%	N/A	0.191%
2/13/2025	Legal & General Group Plc	130,658	$5.72M	0.0%	-1.6%	0.078%
2/13/2025	Invesco Ltd.	117,652	$5.15M	0.0%	-20.1%	0.070%
2/13/2025	ADAR1 Capital Management LLC	170,000	$7.44M	1.5%	+283.3%	0.101%
2/13/2025	Cerity Partners LLC	5,699	$0.25M	0.0%	N/A	0.003%
2/13/2025	FMR LLC	6,742,083	$294.90M	0.0%	+14.7%	4.008%
2/13/2025	Finepoint Capital LP	710,260	$31.07M	1.9%	-3.0%	0.422%
2/13/2025	Russell Investments Group Ltd.	4,243	$0.19M	0.0%	+11.4%	0.003%
2/13/2025	Envestnet Asset Management Inc.	11,425	$0.50M	0.0%	+21.7%	0.007%

Data available starting January 2016

Revolution Medicines, Inc., a clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers. The company's research and development pipeline comprises RAS(ON) inhibitors designed to be used as monotherapy in combination with other RAS(ON) inhibitors and/or in combination with RAS companion inhibitors or other therapeutic agents, and RAS companion inhibitors for combination treatment strategies. Its RAS(ON) inhibitors include RMC-6236 (multi), RMC-6291 (G12C), and RMC-9805 (G12D), which are in phase 1 clinical trial; and development candidates comprise RMC-5127 (G12V), RMC-0708 (Q61H), and RMC-8839 (G13C), as well as programs focused on G12R and other targets. The company's RAS companion inhibitors include RMC-4630 that is in phase 2 clinical trial; and RMC-5552, which is in phase 1 clinical trial. Revolution Medicines, Inc. was incorporated in 2014 and is headquartered in Redwood City, California.

Today's Range

Now: $36.76

$35.82

$36.87

50 Day Range

MA: $37.88

$31.13

$42.34

52 Week Range

Now: $36.76

$29.17

$62.40

Volume

1,274,876 shs

Average Volume

1,422,152 shs

Market Capitalization

$6.83 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.37

Who are the company insiders with the largest holdings of Revolution Medicines?: Revolution Medicines' top insider shareholders include:
Thilo Schroeder (Director)
Mark A Goldsmith (Insider)
Stephen Michael Kelsey (Insider)
Margaret A Horn (COO)
Jack Anders (CFO)
Jeff Cislini (General Counsel)
Sushil Patel (Director)
Barbara Weber (Director)
Learn More about top insider investors at Revolution Medicines.
Who are the major institutional investors of Revolution Medicines?: Revolution Medicines' top institutional investors include:
Rhumbline Advisers — 0.14%
Handelsbanken Fonder AB — 0.02%
Harbor Capital Advisors Inc. — 0.02%
GAMMA Investing LLC — 0.01%
SG Americas Securities LLC — 0.01%
Exchange Traded Concepts LLC — 0.00%
Learn More about top institutional investors of Revolution Medicines stock.
Which institutional investors are selling Revolution Medicines stock?: Within the last quarter, RVMD stock was sold by these institutional investors:
Avanza Fonder AB
Handelsbanken Fonder AB
Exchange Traded Concepts LLC
In the last year, company insiders that have sold Revolution Medicines company stock include:
Thilo Schroeder (Director)
Mark A Goldsmith (Insider)
Stephen Michael Kelsey (Insider)
Margaret A Horn (COO)
Jack Anders (CFO)
Jeff Cislini (General Counsel)
Sushil Patel (Director)
Learn More investors selling Revolution Medicines stock.
Which institutional investors are buying Revolution Medicines stock?: In the last quarter, RVMD stock was purchased by institutional investors including:
Harbor Capital Advisors Inc.
GAMMA Investing LLC
SG Americas Securities LLC
Rhumbline Advisers